Westpac Banking Corp Reduces Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)

Westpac Banking Corp lessened its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 45.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,000 shares of the medical research company’s stock after selling 6,631 shares during the quarter. Westpac Banking […]

Related Keywords

United States ,America ,Robertw Baird ,Jeffrey Thomas Elliott ,Everett Cunningham ,William Blair ,Ameritas Advisory Services ,Securities Exchange Commission ,Wealth Advisors Inc ,Quarter For Exact Sciences ,Westpac Banking Corp ,Sciences Corporation ,Sciences Trading ,Money Concepts Capital Corp ,Goldman Sachs Group ,Exchange Commission ,True Wealth Design ,Nasdaq ,Park Place Capital Corp ,Sciences Profile ,News Ratings For Exact Sciences Daily ,Sciences Co ,Exact Sciences ,Free Report ,Banking Corp ,Place Capital Corp ,Wealth Design ,Advisory Services ,Thomas Elliott ,Recurrence Score Test ,Score Test ,Oncoextra Test ,Visit Holdingschannel ,Exact Sciences Daily ,Nasdaq Exas ,Texas ,Medical ,30063p10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,